Table 1. Demographic characteristics of the study groups.
Group I: Standard antidiabetic medications+ SGLT2 inhibitor; Group II: Standard antidiabetic medications
Data presented as mean ± standard deviation
Comparison between groups performed by the unpaired t-test
* P < 0.05 compared to Group II
| Characteristic | Group I (n=16) | Group II (n=16) |
| Sex (M:F) | 10:6 | 11:5 |
| Age (yrs.) | 50.81 ± 10.21 | 49.75 ± 11.05 |
| Weight (kg) | 70.25 ± 10.88* | 72 ± 9.26 |
| Duration of diabetes (yrs) | 6.75 ± 2.62 | 6.62 ± 3.18 |
| SBP (mmHg) | 128.1 ± 10.86 | 133.4 ± 11.42 |
| DBP (mmHg) | 85.8 ± 8.87 | 87.5 ± 7.06 |